Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in Urology

Retrieve available abstracts of 161 articles:
HTML format
Text format



Single Articles


    May 2018
  1. MEDINA LG, Cacciamani GE, Hernandez A, Landsberger H, et al
    Robotic Management of Recto-Urethral Fistulas after Focal Treatment for Prostate Cancer.
    Urology. 2018 May 22. pii: S0090-4295(18)30469.
    PubMed     Text format     Abstract available


  2. KAYE DR, Qi J, Morgan TM, Linsell S, et al
    Association between Early Confirmatory Testing and the Adoption of Active Surveillance for Men with Favorable-Risk Prostate Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30471.
    PubMed     Text format     Abstract available


  3. BUELENS S, Van Praet C, Poelaert F, Van Huele A, et al
    Prospective, Randomized Controlled Trial Exploring the Effect of TachoSil(R) on Lymphocele Formation after Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Urology. 2018 May 15. pii: S0090-4295(18)30463.
    PubMed     Text format     Abstract available


  4. ZHANG S, Li LH, Qiao HM, Yang X, et al
    Regulation of the Antioxidant-Response by MyoD Transcriptional Coactivator in Castration-Resistant Prostate Cancer Cells.
    Urology. 2018 May 3. pii: S0090-4295(18)30397.
    PubMed     Text format     Abstract available


  5. LI Q, Xiang F, Lin X, Grajo JR, et al
    The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along Ten Imaging Touch Points.
    Urology. 2018 May 3. pii: S0090-4295(18)30395.
    PubMed     Text format     Abstract available


  6. MERRET C, Mannas M, Black PC, Zargar H, et al
    Magnet before the Needle: Commentary on MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (PRECISION Trial).
    Urology. 2018 May 3. pii: S0090-4295(18)30393.
    PubMed     Text format    


    April 2018
  7. LUCKENBAUGH AN, Hollenbeck BK, Kaufman SR, Yan P, et al
    Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer.
    Urology. 2018 Apr 6. pii: S0090-4295(18)30300.
    PubMed     Text format     Abstract available


  8. VELASQUEZ MC, Chinea FM, Kwon D, Prakash NS, et al
    The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality after Radical Prostatectomy in Hispanic/Latino Men: A Population-Based Analysis.
    Urology. 2018 Apr 6. pii: S0090-4295(18)30293.
    PubMed     Text format     Abstract available


    March 2018
  9. KESCH C, Black PC
    Filling a True Unmet Need: a New Therapy for Non-Metastatic Castrate Resistant Prostate Cancer. Commentary on: Apalutamide Treatment and Metastasis-Free Survival in Prostate Cancer.
    Urology. 2018 Mar 26. pii: S0090-4295(18)30260.
    PubMed     Text format    


  10. BJURLIN MA, Turkbey B, Rosenkrantz AB, Gaur S, et al
    Imaging the High-Risk Prostate Cancer Patient: Current and Future Approaches to Staging.
    Urology. 2018 Mar 12. pii: S0090-4295(17)31305.
    PubMed     Text format     Abstract available


    February 2018
  11. RADHAKRISHNAN A, Grande D, Mitra N, Pollack CE, et al
    Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?
    Urology. 2018 Feb 22. pii: S0090-4295(18)30160.
    PubMed     Text format     Abstract available


  12. WOJNO L, Minutella C, Moylan D, Bush A, et al
    Specimen Provenance Testing Identifies Contamination That Affects Molecular Prognostic Assay Results in Prostate Cancer Biopsy Specimens.
    Urology. 2018 Feb 21. pii: S0090-4295(18)30162.
    PubMed     Text format     Abstract available


    January 2018
  13. CANCIAN M, Renzulli JF 2nd
    Non Metastatic Castration Resistant Prostate Cancer: a Modern Perspective.
    Urology. 2018 Jan 18. pii: S0090-4295(18)30044.
    PubMed     Text format     Abstract available


  14. WALLIS CJD, Satkunasivam R, Herschorn S, Law C, et al
    Association between Primary Local Treatment and Non-Prostate Cancer Mortality in Men with Non-Metastatic Prostate Cancer.
    Urology. 2018 Jan 2. pii: S0090-4295(17)31330.
    PubMed     Text format     Abstract available


    December 2017
  15. TANG V, Campbell P, Pattison DA
    Lymphangitic Carcinomatosis From Prostate Cancer Identified with Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging.
    Urology. 2017 Dec 29. pii: S0090-4295(17)31327.
    PubMed     Text format     Abstract available


  16. WERNEBURG GT, Kongnyuy M, Halpern DM, Salcedo JM, et al
    Effects of Focal Versus Total Cryotherapy and Minimum Tumor Temperature on Patient-Reported Quality of Life as Compared to Active Surveillance in Prostate Cancer Patients.
    Urology. 2017 Dec 22. pii: S0090-4295(17)31302.
    PubMed     Text format     Abstract available


  17. KAHOKEHR AA, Peterson AC
    Unmasking of Urinary-Pubic Symphysis Fistula (UPF) after Implantation of Artificial Urinary Sphincter in Prostate Cancer Survivors - User Beware. Url-D-17-02187.
    Urology. 2017 Dec 22. pii: S0090-4295(17)31301.
    PubMed     Text format     Abstract available


  18. ULLMAN D, Dorn D, Rais-Bahrami S, Gordetsky J, et al
    Clinical Utility and Biologic implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer.
    Urology. 2017 Dec 7. pii: S0090-4295(17)31219.
    PubMed     Text format     Abstract available


    November 2017
  19. WALLIS CJD, Satkunasivam R, Saskin R, Bansal S, et al
    Population-Based Analysis of Treatment Toxicity among Men with Castration-Resistant Prostate Cancer: a Phase IV Study.
    Urology. 2017 Nov 27. pii: S0090-4295(17)31221.
    PubMed     Text format     Abstract available



  20. Erratum to "Postoperative Adjuvant and Salvage Radiotherapy for Prostate Cancer: Impact on Freedom From Biochemical Relapse and Survival".
    Urology. 2017 Nov 20. pii: S0090-4295(17)31088.
    PubMed     Text format    


  21. BJURLIN MA, Rosenkrantz AB, Sarkar S, Lepor H, et al
    Prediction of Prostate Cancer Risk among Men Undergoing Combined MRI-Targeted and Systematic Biopsy Using Novel Pre-Biopsy Nomograms That Incorporate MRI Findings.
    Urology. 2017 Nov 16. pii: S0090-4295(17)31185.
    PubMed     Text format     Abstract available


  22. BARQAWI A, Huebner E, Krughoff K, O'Donnell CI, et al
    Prospective Outcome Analysis of the Safety and Efficacy of Partial and Complete Cryoablation in Organ-Confined Prostate Cancer.
    Urology. 2017 Nov 7. pii: S0090-4295(17)31163.
    PubMed     Text format     Abstract available


    October 2017
  23. ZHONG W, Smith B, Haghighi K, Mancuso P, et al
    Systematic Review of Decision Aids for the Management of Men with Localized Prostate Cancer.
    Urology. 2017 Oct 31. pii: S0090-4295(17)31154.
    PubMed     Text format     Abstract available


  24. SHARMA V, Yousefi K, Haddad Z, Buerki C, et al
    Gene Expression Correlates of Site-Specific Metastasis among Men with Lymph Node Positive Prostate Cancer Treated with Radical Prostatectomy: a Case Series.
    Urology. 2017 Oct 24. pii: S0090-4295(17)31099.
    PubMed     Text format     Abstract available


  25. KENIGSBERG AP, Llukani E, Deng FM, Melamed J, et al
    The Use of MRI to Predict Oncological Control among Candidates for Focal Ablation of Prostate Cancer.
    Urology. 2017 Oct 20. pii: S0090-4295(17)31097.
    PubMed     Text format     Abstract available


  26. NGUYEN A, O'Leary MP
    Re: Deebel et al.: Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges (Urology 2017, http://dx.doi.org/doi:10.1016/j.urology.2017.08.032).
    Urology. 2017 Oct 16. pii: S0090-4295(17)31076.
    PubMed     Text format    


    September 2017
  27. QURESHI ZP, Sartor O, Bennett CL
    Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer.
    Urology. 2017 Sep 20. pii: S0090-4295(17)30750.
    PubMed     Text format    


  28. SHORE N, Heidenreich A, Saad F
    Author Response on the Manuscript Titled "Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer" (#URL-D-17-01121).
    Urology. 2017 Sep 20. pii: S0090-4295(17)30751.
    PubMed     Text format    


  29. GOLOMBOS DM, Ayangbesan A, O'Malley P, Lewicki P, et al
    The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: a Prospective, Pilot Study.
    Urology. 2017 Sep 6. pii: S0090-4295(17)30957.
    PubMed     Text format     Abstract available


  30. WIENER S, Haddock P, Cusano J, Staff I, et al
    Incidence of Clinically Significant Prostate Cancer after a Diagnosis of Atypical Small Acinar Proliferation (ASAP), High Grade Prostatic Intraepithelial Neoplasia (HGPIN), or Benign Tissue.
    Urology. 2017 Sep 6. pii: S0090-4295(17)30958.
    PubMed     Text format     Abstract available


  31. DEEBEL NA, Morin JP, Autorino R, Vince R, et al
    Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges.
    Urology. 2017 Sep 4. pii: S0090-4295(17)30906.
    PubMed     Text format     Abstract available


    August 2017
  32. BOESEN L, Norgaard N, Logager V, Balslev I, et al
    Where Do TRUS- and MRI Guided Biopsies Miss Significant Prostate Cancer?
    Urology. 2017 Aug 30. pii: S0090-4295(17)30899.
    PubMed     Text format     Abstract available


  33. FRIEDL A, Stangl K, Bauer W, Kivaranovic D, et al
    Prostate-Specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction with the in-Bore 3-T MRI-Guided Transrectal Targeted Prostate Biopsy after Negative 12-Core Biopsy.
    Urology. 2017 Aug 24. pii: S0090-4295(17)30880.
    PubMed     Text format     Abstract available


  34. OROM H, Biddle C, Underwood W 3rd, Homish GG, et al
    Racial/Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-Specific Quality of Life.
    Urology. 2017 Aug 22. pii: S0090-4295(17)30866.
    PubMed     Text format     Abstract available


  35. BHINDI B, Carlson RE, Mason RJ, Schulte PJ, et al
    Long-Term Follow Up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-Confined Prostate Cancer with a Positive Surgical Margin.
    Urology. 2017 Aug 17. pii: S0090-4295(17)30853.
    PubMed     Text format     Abstract available


  36. AAS K, Axcrona K, Kvale R, Moller B, et al
    10-Year Mortality in Men with Non-Metastatic Prostate Cancer in Norway.
    Urology. 2017 Aug 17. pii: S0090-4295(17)30860.
    PubMed     Text format     Abstract available


  37. SHORE N, Heidenreich A, Saad F
    Predicting Response and Recognizing Resistance: Improving Outcomes in Patients with Castration-Resistant Prostate Cancer.
    Urology. 2017 Aug 7. pii: S0090-4295(17)30745.
    PubMed     Text format     Abstract available


  38. STRUSS WJ, Black PC
    Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-Sensitive Prostate Cancer.
    Urology. 2017 Aug 7. pii: S0090-4295(17)30779.
    PubMed     Text format    


    July 2017
  39. ZACHO HD, Gade M, Mortensen JC, Bertelsen H, et al
    Bone Scan Index is an Independent Predictor for Time to Castration-Resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: a Prospective Study.
    Urology. 2017 Jul 28. pii: S0090-4295(17)30759.
    PubMed     Text format     Abstract available


  40. ZACHO HD, Petersen LJ
    Reply by the authors to the Editorial on: Zacho HD, Gade M, Mortensen JC, Bertelsen H, Boldsen SK, Petersen LJ. Bone scan index is an independent predictor for time to castration resistant prostate cancer in newly diagnosed prostate cancer: A prospect
    Urology. 2017 Jul 26. pii: S0090-4295(17)30760.
    PubMed     Text format    


  41. HORIGUCHI A, Shinchi M, Nakamura A, Wada T, et al
    Pilot Study of Prostate Cancer Angiogenesis Imaging Using a Photoacoustic Imaging System.
    Urology. 2017 Jul 19. pii: S0090-4295(17)30733.
    PubMed     Text format     Abstract available


    June 2017
  42. SKOLARUS TA, Ragnoni JA, Garlinghouse C, Schafenacker A, et al
    Multilingual Self-Management Resources for Prostate Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health Department Partnership to Promote Survivorship Care.
    Urology. 2017 Jun 23. pii: S0090-4295(17)30637.
    PubMed     Text format     Abstract available


  43. GORIN MA, Pienta KJ, Pomper MG, Rowe SP, et al
    Prostate Cancer Local Recurrence Detected with Both 18F-Fluciclovine and PSMA-Targeted 18F-DCFPyL PET/CT.
    Urology. 2017 Jun 19. pii: S0090-4295(17)30635.
    PubMed     Text format     Abstract available


  44. MANNAS M, Chedgy E, Black PC
    You Pays Your Money, You Takes Your Choice: Functional Outcomes Following Curative Treatment for Clinically Localized Prostate Cancer.
    Urology. 2017 Jun 15. pii: S0090-4295(17)30625.
    PubMed     Text format    


  45. GRIVAS N, van der Roest R, Tillier C, Schouten D, et al
    Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging are Correlated with Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-Assisted Radical Prostatectomy for Prostate Cancer.
    Urology. 2017 Jun 7. pii: S0090-4295(17)30604.
    PubMed     Text format     Abstract available


    May 2017
  46. HEGDE JV, Veruttipong D, Said JW, Reiter RE, et al
    Prostate Cancer Antigen 3 (PCA3) Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-Free Survival in Clinically-Localized, Intermediate- and High-Risk Prostate Cancer.
    Urology. 2017 May 25. pii: S0090-4295(17)30565.
    PubMed     Text format     Abstract available


    April 2017
  47. DAVIS K, Bellini P, Hagerman C, Zinar R, et al
    Physicians' Perceptions of Factors Influencing the Treatment Decision-Making Process for Men with Low-Risk Prostate Cancer.
    Urology. 2017 Apr 25. pii: S0090-4295(17)30391.
    PubMed     Text format     Abstract available


  48. CANTIELLO F, Gangemi V, Cascini GL, Calabria F, et al
    Diagnostic Accuracy of 64Cu-PSMA PET/CT for Primary Lymph Node Staging of Intermediate to High Risk Prostate Cancer: Our Preliminary Experience.
    Urology. 2017 Apr 21. pii: S0090-4295(17)30385.
    PubMed     Text format     Abstract available


  49. XIA L, Zeh R, Mizelle J, Newton A, et al
    Near-Infrared Intraoperative Molecular Imaging Can Identify Metastatic Lymph Nodes in Prostate Cancer.
    Urology. 2017 Apr 21. pii: S0090-4295(17)30386.
    PubMed     Text format     Abstract available


  50. POELAERT F, Verbaeys C, Rappe B, Kimpe B, et al
    Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective LoMP Trial.
    Urology. 2017 Apr 20. pii: S0090-4295(17)30372.
    PubMed     Text format     Abstract available


  51. JUE JS, Barboza MP, Prakash NS, Venkatramani V, et al
    Re-Examining PSA Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy.
    Urology. 2017 Apr 18. pii: S0090-4295(17)30368.
    PubMed     Text format     Abstract available


  52. GUERRIOS-RIVERA L, Howard L, Frank J, De Hoedt A, et al
    Is BMI the Best Adiposity Measure for Prostate Cancer Risk? Results From a VA Biopsy Cohort.
    Urology. 2017 Apr 10. pii: S0090-4295(17)30347.
    PubMed     Text format     Abstract available


    March 2017
  53. JOHNSTON J, Struss WJ, Black PC
    Padeliporfin Vascular-Targeted Photodynamic Therapy Versus Active Surveillance in Men with Low-Risk Prostate Cancer (Clin1001 PCM301): an Open-Label, Phase 3, Randomised Control Trial.
    Urology. 2017 Mar 22. pii: S0090-4295(17)30274.
    PubMed     Text format    


  54. STRUSS WJ, Black PC
    Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
    Urology. 2017 Mar 22. pii: S0090-4295(17)30275.
    PubMed     Text format    


  55. PAKZAD R, Safiri S
    Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study; Methodological Issues.
    Urology. 2017 Mar 21. pii: S0090-4295(17)30272.
    PubMed     Text format    


  56. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
    Reply to Letter-to-the-Editor: Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study, Published in Urology. 2017 Jan;99:148-154.
    Urology. 2017 Mar 20. pii: S0090-4295(17)30269.
    PubMed     Text format    


  57. JOSHI A, Nicholson C, Rhee H, Gustafson S, et al
    Incidental Malignancies identified during staging for Prostate Cancer with 68Ga -PSMA HBED-CC PET imaging.
    Urology. 2017 Mar 20. pii: S0090-4295(17)30271.
    PubMed     Text format     Abstract available


  58. LU AJ, Syed JS, Nguyen KA, Nawaf CB, et al
    Negative Multi-Parametric MRI of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy.
    Urology. 2017 Mar 16. pii: S0090-4295(17)30247.
    PubMed     Text format     Abstract available


  59. PAKZAD R, Safiri S
    Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer: Methodological Issues.
    Urology. 2017 Mar 15. pii: S0090-4295(17)30244.
    PubMed     Text format    



  60. Erratum to "Predictors of Time to Metastasis in Castration-resistant Prostate Cancer".
    Urology. 2017 Mar 14. pii: S0090-4295(17)30113.
    PubMed     Text format    


  61. CRAWFORD ED, Petrylak DP, Shore N, Saad F, et al
    The Role of Therapeutic Layering in Optimizing Treatment for Patients with Castration-Resistant Prostate Cancer (RADAR II).
    Urology. 2017 Mar 13. pii: S0090-4295(16)31023.
    PubMed     Text format     Abstract available


    February 2017
  62. GORDETSKY J, Rais-Bahrami S, Epstein JI
    Pathological Findings in Multiparametric MRI/Ultrasound Fusion Guided Biopsy: Relation to Prostate Cancer Focal Therapy.
    Urology. 2017 Feb 23. pii: S0090-4295(17)30163.
    PubMed     Text format     Abstract available


  63. AUFFENBERG GB, Merdan S, Miller DC, Singh K, et al
    Evaluation of Prostate Cancer Risk Calculators for Shared-Decision Making Across Diverse Urology Practices in Michigan.
    Urology. 2017 Feb 22. pii: S0090-4295(17)30165.
    PubMed     Text format     Abstract available


  64. LANG MF, Tyson MD, Rudd Alvarez J, Koyama T, et al
    The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-Based Cohort.
    Urology. 2017 Feb 9. pii: S0090-4295(17)30123.
    PubMed     Text format     Abstract available


  65. GUNLUSOY B, Ceylan Y, Koskderlioglu A, Gedizlioglu M, et al
    Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer.
    Urology. 2017 Feb 7. pii: S0090-4295(17)30116.
    PubMed     Text format     Abstract available


  66. KIRK PS, Govani S, Borza T, Hollenbeck BK, et al
    Implications of Prostate Cancer Treatment in Men with Inflammatory Bowel Disease.
    Urology. 2017 Feb 2. pii: S0090-4295(17)30111.
    PubMed     Text format     Abstract available


  67. JOHNSON SC, Packiam VT, Golan S, Cohen AJ, et al
    The Effect of Obesity on Perioperative Outcomes for Open and Minimally Invasive Prostatectomy.
    Urology. 2017;100:111-116.
    PubMed     Text format     Abstract available


  68. BORHAN W, Epstein JI
    Significance of Gleason Score 7 With Tertiary Pattern 5 at Radical Prostatectomy.
    Urology. 2017;100:175-179.
    PubMed     Text format     Abstract available


  69. KOMINSKY HD, Bashline M, Eun D, Pontari MA, et al
    Use of Age and Medical Comorbidity to Assess Long-term Other-cause Mortality Risk in a Cohort of Men Undergoing Prostate Biopsy at an Academic Medical Center.
    Urology. 2017;100:169-174.
    PubMed     Text format     Abstract available


    January 2017
  70. LIU JZ, Yin FY, Yan CY, Wang H, et al
    Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by Hsa-miR-125A-3P via Modulation of MTA1 Signaling.
    Urology. 2017 Jan 11. pii: S0090-4295(17)30013.
    PubMed     Text format     Abstract available


  71. FROEHNER M, Kuithan F, Zophel K, Heberling U, et al
    Prostate-specific Membrane Antigen-targeted Ligand Positron Emission Tomography/Computed Tomography and Immunohistochemical Findings in a Patient With Synchronous Metastatic Penile and Prostate Cancer.
    Urology. 2017 Jan 4. pii: S0090-4295(16)30923.
    PubMed     Text format     Abstract available


  72. ZARGAR-SHOSHTARI K, Lawrentschuk N, Zargar H
    Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery: Commentary on: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study.
    Urology. 2017;99:3-4.
    PubMed     Text format    


    December 2016
  73. FREITAS D, Andriole GL, Castro-Santamaria R, Freedland SJ, et al
    Extent of Baseline Prostate Atrophy is Associated with Lower Incidence of Low- and High-Grade Prostate Cancer on Repeat Biopsy.
    Urology. 2016 Dec 23. pii: S0090-4295(16)31014.
    PubMed     Text format     Abstract available


  74. KIM EH, Weaver JK, Shetty AS, Vetter JM, et al
    Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients with Estimated Risk of High Grade Prostate Cancer Less Than or Equal to 10.
    Urology. 2016 Dec 2. pii: S0090-4295(16)30917.
    PubMed     Text format     Abstract available


    November 2016
  75. ODERDA M, Cozzi G, Daniele L, Sapino A, et al
    CCP-Score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer Patients.
    Urology. 2016 Nov 25. pii: S0090-4295(16)30914.
    PubMed     Text format     Abstract available


  76. O'SHAUGHNESSY MJ, McBride SM, Vargas HA, Touijer KA, et al
    A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early Stage Metastatic Prostate Cancer.
    Urology. 2016 Nov 22. pii: S0090-4295(16)30850.
    PubMed     Text format     Abstract available


  77. TURNER RM 2ND, Yecies TS, Yabes JG, Ristau BT, et al
    Biopsy Perineural Invasion in Prostate Cancer Patients Who are Candidates for Active Surveillance by Strict and Expanded Criteria.
    Urology. 2016 Nov 15. pii: S0090-4295(16)30826.
    PubMed     Text format     Abstract available


  78. GOMEZ-GOMEZ E, Carrasco-Valiente J, Blanca-Pedregosa A, Barco-Sanchez B, et al
    European Randomised Study for Screening of Prostate Cancer Risk Calculator: External Validation, Variability and Clinical Significance.
    Urology. 2016 Nov 10. pii: S0090-4295(16)30808.
    PubMed     Text format     Abstract available


    October 2016
  79. CUTRUZZULA P, Edwards D, Cahn D, Tong C, et al
    Metastatic Prostate Cancer Presenting as Lower Extremity Soft Tissue Mass: a Rare Case Presentation.
    Urology. 2016 Oct 17. pii: S0090-4295(16)30710.
    PubMed     Text format     Abstract available


  80. LEAPMAN M, Jazayeri SB, Katsigeorgis M, Hobbs A, et al
    Patient-Perceived Causes of Prostate Cancer: Result of an Internet Based Survey.
    Urology. 2016 Oct 17. pii: S0090-4295(16)30707.
    PubMed     Text format     Abstract available


  81. BOISSIER R, Udrescu C, Rebillard X, Terrier JE, et al
    Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
    Urology. 2016 Oct 7. pii: S0090-4295(16)30699.
    PubMed     Text format     Abstract available


  82. JONES TA, Natarajan S, Priester AM, Marks LS, et al
    Images in Clinical Urology - Focal Laser Ablation of Prostate Cancer.
    Urology. 2016 Oct 6. pii: S0090-4295(16)30700.
    PubMed     Text format     Abstract available


    September 2016
  83. MOSES KA, Orom H, Brasel A, Gaddy J, et al
    Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter.
    Urology. 2016 Sep 22. pii: S0090-4295(16)30579.
    PubMed     Text format     Abstract available


  84. RUDICHUK L, Vogel KJ, Wang CH, Helfand BT, et al
    Urologists' Current Practices in Screening and Treating Men with a Family History of Prostate Cancer.
    Urology. 2016 Sep 16. pii: S0090-4295(16)30460.
    PubMed     Text format     Abstract available


  85. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
    Unexplained Bone Pain Is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: A Prospective Study.
    Urology. 2016 Sep 16. pii: S0090-4295(16)30625.
    PubMed     Text format     Abstract available


  86. SISSUNG TM, Venzon DJ, Figg WD
    Erratum to: Association of a CYP17 Polymorphism With Overall Survival in Caucasian Patients With Androgen-independent Prostate Cancer.
    Urology. 2016;95:225.
    PubMed     Text format    


  87. EGEVAD L, Samaratunga H, Srigley JR, Delahunt B, et al
    Consensus Guidelines for Reporting Prostate Cancer Gleason Grade.
    Urology. 2016 Sep 1. pii: S0090-4295(16)30402.
    PubMed     Text format    


  88. TAN WP, Lin C, Chen M, Deane L, et al
    Periprostatic Fat: A Risk Factor for Prostate Cancer?
    Urology. 2016 Sep 1. pii: S0090-4295(16)30551.
    PubMed     Text format     Abstract available


    August 2016
  89. GHABILI K, Tosoian JJ, Schaeffer EM, Pavlovich CP, et al
    The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies.
    Urology. 2016 Aug 31. pii: S0090-4295(16)30547.
    PubMed     Text format    


  90. LAVIEN G, Chery G, Zaid UB, Peterson AC, et al
    Pubic Bone Resection Provides Objective Pain Control in the Prostate Cancer Survivor with Pubic Bone Osteomyelitis with an Associated Urinary Tract to Pubic Symphysis Fistula.
    Urology. 2016 Aug 31. pii: S0090-4295(16)30550.
    PubMed     Text format     Abstract available


  91. FENSTERMAKER M, Mendhiratta N, Bjurlin MA, Meng X, et al
    Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.
    Urology. 2016 Aug 22. pii: S0090-4295(16)30535.
    PubMed     Text format     Abstract available


  92. KIM SP, Karnes RJ, Gross CP, Meropol NJ, et al
    Contemporary National Trends of Prostate Cancer Screening among Privately Insured Men in the United States.
    Urology. 2016 Aug 12. pii: S0090-4295(16)30512.
    PubMed     Text format     Abstract available


  93. WALLIS CJ, Mahar AL, Satkunasivam R, Herschorn S, et al
    Cardiovascular and Skeletal-Related Events Following Localised Prostate Cancer Treatment: Role of Surgery, Radiotherapy and Androgen-Deprivation.
    Urology. 2016 Aug 5. pii: S0090-4295(16)30494.
    PubMed     Text format     Abstract available


  94. LIU JS, Hofer MD, Sheth KR, Cordon BH, et al
    Improving Outcomes of Bulbomembranous Urethroplasty for Radiation-Induced Urethral Strictures in Post-Urolume Era.
    Urology. 2016 Aug 2. pii: S0090-4295(16)30459.
    PubMed     Text format     Abstract available


    July 2016
  95. HOFER MD, Morey AF, Sheth K, Tausch TJ, et al
    Low Serum Testosterone Level Predisposes to Artificial Urinary Sphincter Cuff Erosion.
    Urology. 2016 Jul 20. pii: S0090-4295(16)30422.
    PubMed     Text format     Abstract available


  96. CRAWFORD ED, Rosenberg MT, Partin AW, Cooperberg MR, et al
    An Approach Using PSA Levels of 1.5 ng/ml as the Cutoff for Prostate Cancer Screening in Primary Care.
    Urology. 2016 Jul 19. pii: S0090-4295(16)30383.
    PubMed     Text format    


  97. KLEIN EA, Smith JA, Zietman AL, Dasgupta P, et al
    Reply to the Letter to the Editor #16-01352: "Consensus Guidelines for Reporting Prostate Cancer Gleason Grade" by Hemamali Samaratunga.
    Urology. 2016 Jul 18. pii: S0090-4295(16)30401.
    PubMed     Text format    


  98. MORGIA G, Russo GI, Tubaro A, Bortolus R, et al
    Prevalence of Cardiovascular Disease and Osteoporosis during Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multi-Center Cross-Sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study.
    Urology. 2016 Jul 8. pii: S0090-4295(16)30315.
    PubMed     Text format     Abstract available


  99. ADEJORO O, Alishahi A, Konety B
    Association of Comorbidity, Age and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
    Urology. 2016 Jul 7. pii: S0090-4295(16)30303.
    PubMed     Text format     Abstract available


  100. LESTER-COLL NH, Park HS, Rutter CE, Corso CD, et al
    The Association between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-Risk Prostate Cancer.
    Urology. 2016 Jul 5. pii: S0090-4295(16)30371.
    PubMed     Text format     Abstract available


    June 2016
  101. ZHANG JH, Reichard CA, Plesec TP, Klein EA, et al
    A Case of Prostate Cancer in Lynch Syndrome.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30289.
    PubMed     Text format    


  102. MOREIRA DM, Howard LE, Sourbeer KN, Amarasekara HS, et al
    Predictors of Time to Metastasis in Castration-Resistant Prostate Cancer.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30294.
    PubMed     Text format     Abstract available


  103. WANG EH, Yu JB, Abouassally R, Meropol NJ, et al
    Disparities in Treatment of Patients with High-Risk Prostate Cancer: Results From A Population-Based Cohort.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30293.
    PubMed     Text format     Abstract available


  104. WU FJ, Sheu SY, Lin HC, Chung SD, et al
    Increased Fall Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30299.
    PubMed     Text format     Abstract available


  105. WALLIS CJ, Mahar AL, Cheung P, Herschorn S, et al
    Hospitalizations to Manage Complications of Modern Prostate Cancer Treatment in Older Men.
    Urology. 2016 Jun 8. pii: S0090-4295(16)30265.
    PubMed     Text format     Abstract available


  106. SHAH N, Ioffe V
    Re: The Memorial Sloan Kettering cancer center recommendations for prostate cancer screening. Andrew J Vickers et al. Urology 91: 12-18, 2016.
    Urology. 2016 Jun 1. pii: S0090-4295(16)30260.
    PubMed     Text format    


  107. VICKERS AJ, Eastham JA, Scardino PT, Lilja H, et al
    Reply to RE: The Memorial Sloan Kettering Cancer Center recommendations for prostate cancer screening.
    Urology. 2016 Jun 1. pii: S0090-4295(16)30257.
    PubMed     Text format    


    May 2016
  108. COHEN A, Lapin B, Wang CH, Helfand B, et al
    Variation in Testosterone Levels and Health Related Quality of Life in Men Diagnosed with Prostate Cancer on Active Surveillance.
    Urology. 2016 May 11. pii: S0090-4295(16)30152.
    PubMed     Text format     Abstract available


  109. SUN Y, Jia X, Hou L, Liu X, et al
    Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data.
    Urology. 2016 May 11. pii: S0090-4295(16)30149.
    PubMed     Text format     Abstract available


  110. HANSEN NL, Caglic I, Berman LH, Kastner C, et al
    Multiparametric Prostate MRI and Cognitively Targeted Transperineal Biopsy in Patients with Previous Abdominoperineal Resection and Suspicion of Prostate Cancer.
    Urology. 2016 May 4. pii: S0090-4295(16)30141.
    PubMed     Text format     Abstract available


  111. QUINTANA L, Ward A, Gerrin SJ, Genega EM, et al
    Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.
    Urology. 2016;91:143-9.
    PubMed     Text format     Abstract available


  112. KARATZAS AD, Zachos I, Mitrakas L, Dimitropoulos K, et al
    Generalized Lymphadenopathy of Prostate Adenocarcinoma Origin. A Case Series.
    Urology. 2016;91:e3-4.
    PubMed     Text format     Abstract available


  113. DASON S, Allard CB, Wright I, Shayegan B, et al
    Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique.
    Urology. 2016;91:129-35.
    PubMed     Text format     Abstract available


    April 2016
  114. IREMASHVILI V, Kava BR, Manoharan M, Parekh DJ, et al
    Is It Time to Revisit the Role of Prostate-Specific Antigen Kinetics in Active Surveillance for Prostate Cancer?
    Urology. 2016 Apr 26. pii: S0090-4295(16)30111.
    PubMed     Text format     Abstract available


  115. SERTKAYA Z
    Re: Fascelli M, Et Al. Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy-Naive Patient Population.
    Urology. 2016 Apr 22. pii: S0090-4295(16)30106.
    PubMed     Text format    


  116. VAN ASSELDONK B, Black P, Elterman DS
    Chemical vs Surgical ADT in Metastatic Prostate Cancer: A Comparison of Side Effects.
    Urology. 2016 Apr 20. pii: S0090-4295(16)30059.
    PubMed     Text format    


  117. DASKIVICH TJ, Lai J, Dick AW, Setodji CM, et al
    Questioning the Ten-Year Life Expectancy Rule for High-Grade Prostate Cancer: Comparative Effectiveness of Aggressive Vs. Non-Aggressive Treatment of High-Grade Disease in Older Men with Differing Comorbid Disease Burdens.
    Urology. 2016 Apr 11. pii: S0090-4295(16)30064.
    PubMed     Text format     Abstract available


  118. KLEIN EA, Haddad Z, Yousefi K, Lam LL, et al
    Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.
    Urology. 2016;90:148-52.
    PubMed     Text format     Abstract available


  119. SCHWEN ZR, Tosoian JJ, Sokoll LJ, Mangold L, et al
    Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men.
    Urology. 2016;90:136-40.
    PubMed     Text format     Abstract available


  120. BENSON MC
    Editorial Comment.
    Urology. 2016;90:147.
    PubMed     Text format    


  121. KROUWEL EM, Elzevier HW
    Author Reply.
    Urology. 2016;90:25-6.
    PubMed     Text format    


  122. NIEDER AM
    Editorial Comment.
    Urology. 2016;90:25.
    PubMed     Text format    


    March 2016
  123. BHINDI B, Xie WY, Kulkarni GS, Hamilton RJ, et al
    Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy.
    Urology. 2016 Mar 22. pii: S0090-4295(16)00302.
    PubMed     Text format     Abstract available


  124. ZIETMAN A, Smith J, Klein E, Droller M, et al
    Consensus Guidelines for Reporting Prostate Cancer Gleason Grade.
    Urology. 2016 Mar 22. pii: S0090-4295(16)00280.
    PubMed     Text format    


  125. OSTBY-DEGLUM M, Axcrona K, Brennhovd B, Dahl AA, et al
    Ability to Reach Orgasm in Patients with Prostate Cancer Treated with Robot-assisted Laparoscopic Prostatectomy.
    Urology. 2016 Mar 10. pii: S0090-4295(16)00285.
    PubMed     Text format     Abstract available


  126. MANDEL P, Kriegmair MC, Veleva V, Salomon G, et al
    The Role of Pelvic Lymph Node Dissection during Radical Prostatectomy in Patients with Gleason Grade 6 Intermediate-Risk Prostate Cancer.
    Urology. 2016 Mar 8. pii: S0090-4295(16)00276.
    PubMed     Text format     Abstract available


  127. KISS B, Thoeny HC, Studer UE
    Current Status of Lymph Node Imaging in Bladder and Prostate Cancer.
    Urology. 2016 Mar 7. pii: S0090-4295(16)00182.
    PubMed     Text format     Abstract available


    February 2016
  128. SHORE ND, Crawford ED, Higano CS, Sartor O, et al
    Advancing Treatment Strategies in Metastatic Castration-resistant Prostate Cancer: The Urologists Role.
    Urology. 2016 Feb 25. pii: S0090-4295(15)01158.
    PubMed     Text format    


  129. DE SANTIS M, Saad F
    Practical Guidance on the Role of Corticosteroids in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
    Urology. 2016 Feb 18. pii: S0090-4295(16)00146.
    PubMed     Text format     Abstract available


  130. PETRELLI F, Vavassori I, Cabiddu M, Coinu A, et al
    Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: a Systematic Review and Meta-Analysis.
    Urology. 2016 Feb 16. pii: S0090-4295(16)00127.
    PubMed     Text format     Abstract available


  131. KLAFF R, Rosell J, Varenhorst E, Sandblom G, et al
    The Long-Term Disease-Specific Mortality of Low-Risk Localized Prostate Cancer: a Prospective Population-Based Register Study Over Two Decades.
    Urology. 2016 Feb 12. pii: S0090-4295(16)00126.
    PubMed     Text format     Abstract available


  132. GAYLIS F, Cohen E, Calabrese R, Prime H, et al
    Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage and Improve?
    Urology. 2016 Feb 11. pii: S0090-4295(16)00112.
    PubMed     Text format     Abstract available


  133. VICKERS AJ, Eastham JA, Scardino PT, Lilja H, et al
    The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.
    Urology. 2016 Feb 2. pii: S0090-4295(16)00070.
    PubMed     Text format     Abstract available


  134. GEORGE AK, Rais-Bahrami S, Fascelli M, Turkbeyc B, et al
    Author Reply.
    Urology. 2016;88:133-4.
    PubMed     Text format    


  135. HOIMES CJ, Madabhushi A
    Editorial Comment.
    Urology. 2016;88:132-3.
    PubMed     Text format    


  136. BAKER D
    Editorial Comment.
    Urology. 2016;88:41-2.
    PubMed     Text format    


  137. SHIKANOV S
    Editorial Comment.
    Urology. 2016;88:41.
    PubMed     Text format    


  138. PAICH K, Wittmann D
    Author Reply.
    Urology. 2016;88:42.
    PubMed     Text format    


    January 2016
  139. KRYVENKO ON
    Re: PSA Mass Density - a Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity Related PSA Hemodilution: Author's Reply.
    Urology. 2016 Jan 25. pii: S0090-4295(16)00074.
    PubMed     Text format    


  140. PISHGAR F
    Re: PSA Mass Density - a Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity Related PSA Hemodilution.
    Urology. 2016 Jan 22. pii: S0090-4295(16)00073.
    PubMed     Text format    


  141. RAI BP, Baum R, Patel A, Hughes R, et al
    The Role PET with Gallium (Ga)-Labelled Prostate-Specific Membrane Antigen (PSMA) in the Management of Patient with Organ Confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and after Radical Prostatectomy.
    Urology. 2016 Jan 11. pii: S0090-4295(16)00011.
    PubMed     Text format     Abstract available


  142. KRYVENKO ON, Diaz M, Matoso A, Kates M, et al
    PSA Mass Density - A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity: Related PSA Hemodilution.
    Urology. 2016 Jan 7. pii: S0090-4295(16)00002.
    PubMed     Text format     Abstract available


  143. KROUWEL EM, Palacios LA, Putter H, Pelger RC, et al
    Omissions in Urology Residency Training Regarding Sexual Dysfunction Subsequent to Prostate Cancer Treatment: Identifying a Need.
    Urology. 2016 Jan 6. pii: S0090-4295(15)01194.
    PubMed     Text format     Abstract available


  144. HENSEL J, Thalmann GN
    Biology of Bone Metastases in Prostate Cancer.
    Urology. 2016 Jan 5. pii: S0090-4295(15)01193.
    PubMed     Text format     Abstract available


  145. NGUYEN PL
    Editorial comment.
    Urology. 2016;87:152.
    PubMed     Text format    


  146. MOUL JW
    Editorial comment.
    Urology. 2016;87:131-2.
    PubMed     Text format    


  147. REEVES F, Everaerts W, Murphy DG, Kiers L, et al
    Stimulation of the Neurovascular Bundle Results in Rhabdosphincter Contraction in a Proportion of Men Undergoing Radical Prostatectomy.
    Urology. 2016;87:133-9.
    PubMed     Text format     Abstract available


    December 2015
  148. CHEDGY EC, Black PC
    "Moving Beyond the Androgen Receptor in Advanced Prostate Cancer".
    Urology. 2015 Dec 23. pii: S0090-4295(15)01107.
    PubMed     Text format    


  149. BRAND TC, Zhang N, Crager MR, Maddala T, et al
    Patient-Specific Meta-Analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.
    Urology. 2015 Dec 23. pii: S0090-4295(15)01142.
    PubMed     Text format     Abstract available


  150. FASCELLI M, Rais-Bahrami S, Sankineni S, Brown AM, et al
    Combined Biparametric Prostate MRI and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy Naive Patient Population.
    Urology. 2015 Dec 8. pii: S0090-4295(15)01091.
    PubMed     Text format     Abstract available


    November 2015
  151. JAROW JP, Ahmed HU, Choyke PL, Taneja SS, et al
    Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop.
    Urology. 2015 Nov 24. pii: S0090-4295(15)01066.
    PubMed     Text format     Abstract available


    October 2015
  152. LEPOR H
    Reply: To PMID 26163812.
    Urology. 2015;86:788-9.
    PubMed     Text format    


  153. MOUL JW
    Editorial Comment.
    Urology. 2015;86:788.
    PubMed     Text format    


  154. JOHNSON D
    Editorial Comment.
    Urology. 2015;86:823.
    PubMed     Text format    


  155. PACKIAM VT, Patel SG, Pariser JJ, Richards KA, et al
    Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate.
    Urology. 2015;86:777-82.
    PubMed     Text format     Abstract available


  156. MURPHY G, Haddock P, Doak H, Jackson M, et al
    Urinary Bother as a Predictor of Postsurgical Changes in Urinary Function After Robotic Radical Prostatectomy.
    Urology. 2015;86:817-23.
    PubMed     Text format     Abstract available


    September 2015
  157. NASSIRI N, Natarajan S, Margolis DJ, Marks LS, et al
    Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology.
    Urology. 2015;86:432-8.
    PubMed     Text format     Abstract available


  158. MARKOWSKI MC, Eisenberger MA, Zahurak M, Epstein JI, et al
    Sarcomatoid Carcinoma of the Prostate: Retrospective Review of a Case Series From the Johns Hopkins Hospital.
    Urology. 2015;86:539-43.
    PubMed     Text format     Abstract available


  159. LOEB S
    Editorial Comment.
    Urology. 2015;86:504-5.
    PubMed     Text format    


  160. BRAWLEY OW
    Editorial Comment.
    Urology. 2015;86:504.
    PubMed     Text format    


  161. WALLNER LP, Loo RK, Jacobsen SJ
    Reply: To PMID 26123517.
    Urology. 2015;86:505.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: